Dhanlaxmi Crop Science Ltd. (DHANLAXMI.NS)

Dhanlaxmi Crop Science Ltd. (DHANLAXMI.NS) — VMCI valuation read

Headline read on DHANLAXMI.NS: VMCI of 57/100 versus a Consumer Defensive sector median of 50. The 7-point above-median position is what makes Dhanlaxmi Crop Science Ltd. a relative-value candidate in the mid-cap cohort, before any pillar-level review.

Form 4 filings on DHANLAXMI.NS: zero in the trailing 30 days. The absence of insider transactions is itself a data point, just a low-information one. The thesis runs on financials and price action until that changes.

**Investor frame.** Three reads on DHANLAXMI.NS: value (DHANLAXMI.NS trades at 23.0x earnings, 28% above the Consumer Defensive median of 18.0x), quality (ROIC of 11.0% sits 1.0pp above the Consumer Defensive median (10.0%)), and risk (net debt to EBITDA of -2.2x leaves covenant headroom). The value read also implies an EV/EBITDA gap of +4.0x against the Consumer Defensive 12.0x baseline.

DHANLAXMI.NS rose 3.0% over the trailing 7 days, with a +1.2% read on a 30-day basis.